Article
Sequential CRISPR gene editing in human iPSCs charts the clonal evolution of myeloid leukemia and identifies early disease targets.
Cell stem cell - 3 Jun 2021
Wang Tiansu, Pine Allison R, Kotini Andriana G, Yuan Han, Zamparo Lee, Starczynowski Daniel T, Leslie Christina, Papapetrou Eirini P
Abstract excerpt
Human cancers arise through the sequential acquisition of somatic mutations that create successive clonal populations. Human cancer evolution models could help illuminate this process and inform therapeutic intervention at an early disease stage, but their creation has faced significant challenges. Here, we combined induced pluripotent stem cell (iPSC) and CRISPR-Cas9 technologies to develop a model of the clonal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
